Clinical Trials Directory

Trials / Completed

CompletedNCT00920244

In-hospital Cardiac Arrest - Dynamics and State Transitions

Dynamics and State Transitions During Resuscitation in In-hospital Cardiac Arrest

Status
Completed
Phase
Study type
Observational
Enrollment
285 (actual)
Sponsor
St. Olavs Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to analyse transitions in cardiac rhythm and hemodynamic variables during resuscitation of patients with in-hospital cardiac arrest.

Detailed description

In-hospital cardiac arrest carries a grave prognosis, with survival to discharge in the range of 15-20%. Key factors determining outcome include the presenting cardiac rhythm, aetiology, and early initiation of resuscitation. Some cardiac rhythms benefit from defibrillation (shockable rhythms). During resuscitation patients may switch between shockable and non-shockable rhythms, and may show signs of spontaneous circulation temporarily. Depending on rhythm and according to guidelines, patients receive direct current (DC) shocks (defibrillator) and/or i.v. adrenaline, atropine and amiodarone, which may affect state-transitions. We wish to make statistical analysis (time-series analysis, Markov modelling) of these state-transitions and variations in hemodynamic variables during resuscitation, related to CPR interventions and the cause of arrest. The cause of arrest will be determined based on chart records, interview with staff and autopsy if appropriate. One hypothesis is that differences in the patterns of state-transitions may reflect underlying aetiology, which may guide in future decision-making during resuscitation.

Conditions

Interventions

TypeNameDescription
PROCEDURECardiopulmonary resuscitation (CPR)CPR is performed according to international and national guidelines on all patients.
DRUGEpinephrineAccording to guidelines epinephrine 1 mg i.v. is administered every 3 minutes during cardiopulmonary resuscitation.
DRUGAtropineAccording to CPR guidelines atropine 3 mg i.v. is administered if asystole og PEA with frequency \< 60 beat/min.
DRUGAmiodaroneAccording to guidelines amiodarone 300 mg i.v. is administered if recurrent ventricular fibrillation/tachycardia (VF/VT) during CPR.
DEVICEExternal defibrillatorAccording to CPR guidelines patients with shockable rhythms may receive DC shocks. The defibrillator also stores physiological information regarding cardiac rhythm, pulse-oximetry, and end-tidal carbon dioxide (CO2) from endotracheal tube.

Timeline

Start date
2009-08-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2009-06-15
Last updated
2018-09-05

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00920244. Inclusion in this directory is not an endorsement.